Internal Medicine, Nephrology · Santa Ana, CA
NPI
1619964368
Since 2005
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
0
Medicare group memberships
Hospitals
3
Hospital affiliations
4718 W 1st St Unit 100
Santa Ana, CA, 92703
Phone (714) 408-0488
Medicare paid, 2024
$249K
4,000 services
Medicare patients, 2024
473
Average age 76
Drug cost, 2024
$2.2M
22,829 prescriptions
Company payments, 2025
$2,081
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Minh C DO was code 99213 (office e&m - established), 2,718 times for 449 patients. In total Minh C DO billed 4,000 services in 13 codes, and Medicare paid $249K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-03-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 2,718 | 449 | $62.81 | $171K |
| 99232 Hospital E&M - Subsequent | Facility | 344 | 43 | $60.65 | $21K |
| 36410 Vascular | Office | 292 | 203 | $11.82 | $3,452 |
| G0008 Administration of influenza virus vaccine | Office | 216 | 216 | $35.02 | $7,564 |
| 90662 Vaccine Product | Office | 212 | 212 | $52.98 | $11K |
| 99222 Hospital E&M - Initial | Facility | 59 | 43 | $98.84 | $5,832 |
| 99203 Office E&M - New | Office | 40 | 40 | $76.74 | $3,070 |
| 99496 Chronic, Principal, and Transitional Care Management | Office | 19 | 18 | $227.41 | $4,321 |
By year: 2022 $311K for 4,483 services; 2023 $315K for 4,610 services; 2024 $249K for 4,000 services.
Medicare prescription drug claims, 2024
In 2024, the drug Minh C DO prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,421 prescriptions and refills. In total Minh C DO wrote 22,829 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,421 | 3,386 | 343 | $9,388 |
| Levocetirizine Dihydrochloride Generic | 1,038 | 2,280 | 322 | $11K |
| Fluticasone Propionate Generic | 896 | 1,772 | 264 | $13K |
| Triamcinolone Acetonide Generic | 763 | 1,250 | 208 | $11K |
| Metformin Hcl Generic | 673 | 1,647 | 161 | $3,417 |
| Amlodipine Besylate Generic | 672 | 1,602 | 167 | $2,160 |
| Losartan Potassium Generic | 583 | 1,418 | 144 | $4,185 |
| Omeprazole Generic | 457 | 1,112 | 135 | $4,158 |
| Gabapentin Generic | 435 | 924 | 118 | $5,613 |
| Meloxicam Generic | 418 | 878 | 134 | $1,165 |
| Metoprolol Succinate Generic | 399 | 870 | 89 | $4,711 |
| Naproxen Generic | 371 | 798 | 122 | $4,985 |
| Donepezil Hcl Generic | 363 | 821 | 105 | $2,264 |
| Famotidine Generic | 351 | 834 | 117 | $2,570 |
| Tamsulosin Hcl Generic | 330 | 769 | 94 | $2,641 |
Brand drugs: 2,292 claims; generic drugs: 20,178 claims; opioid claims: 270.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Minh C DO $2,081 ($2,081 in general payments such as food, travel and fees) from 15 companies. The largest payer was Aimmune Therapeutics, Inc. with $463.
| Company | Payments | Amount |
|---|---|---|
| Aimmune Therapeutics, Inc. | 20 | $463 |
| AstraZeneca Pharmaceuticals LP AZN | 12 | $341 |
| Galderma Laboratories, L.P. GALD.SW | 2 | $269 |
| Abbvie Inc. ABBV | 18 | $232 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 10 | $178 |
| Genzyme Corporation SNY | 1 | $126 |
| LEO Pharma Inc. | 1 | $122 |
| Travere Therapeutics, Inc. TVTX | 4 | $88.98 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $78.81 |
| Amgen Inc. AMGN | 3 | $66.1 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.